Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194597 · ClinicalTrials.gov registry record · Phase 4
Trial of Viagra' in Men With Chronic Pelvic Pain Syndrome Type III
A Phase 4 study, sponsored by University of Washington.
- Terminated
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT00194597 is a Phase 4 study that was terminated before completion, run by University of Washington. The registered enrollment target is 30 participants.
The verdict
NCT00194597, a Phase 4 study, was terminated before completion, sponsored by University of Washington.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
Viagra is a potent 5-PDE inhibitor that causes vasodilation in the penis and, therefore, erection in men with erectile dysfunction. Our hypothesis is that Viagra may improve the symptoms of men with Chronic Pelvic Pain Syndrome based on the following assumptions: Chronic Pelvic Pelvic Syndrome and Interstitial Cystitis involve poorly understood central and peripheral pain sensitization such as are seen in Chronic Sympathetic Dystrophy, also called Chronic Regional Pain Syndrome. This pain may be caused by constricted blood vessels resulting from past stress, injury or trauma Viagra will dilate sympathetically constricted vessels and improve pelvic blood flow in the same manner it does in men with erectile dysfunction. Since men with Chronic Pelvic Pain Syndrome often complain of sexual dysfunction; improving sexual function and, therefore, quality of life may improve overall well being and perception of pain.
Interventions
- DRUG Viagra (sildenafil citrate)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2004-07 |
| Est. Completion | 2007-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00194597
The ClinicalTrials.gov registry entry for NCT00194597 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Viagra (sildenafil citrate) is the first listed.
NCT00194597 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00194597 about?
NCT00194597 is a clinical study titled "Trial of Viagra' in Men With Chronic Pelvic Pain Syndrome Type III". Viagra is a potent 5-PDE inhibitor that causes vasodilation in the penis and, therefore, erection in men with erectile dysfunction. Our hypothesis is that Viagra may improve the symptoms of men with Chronic Pelvic Pain Syndrome based on the following assumptions: Chronic Pelvic Pelvic Syndrome and ...
What is the current status of trial NCT00194597?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2004-07. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00194597?
The interventions under investigation include: Viagra (sildenafil citrate) (DRUG).
Who is sponsoring clinical trial NCT00194597?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.